Screener
Segment Expenditure Addition To Long Lived Assets
Gyre Therapeutics, Inc.·Business Segments·3 segments·Rolls up to Property, plant, and equipment additions
| Segment | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Gyre Pharmaceuticals | $693K | $0 | $122K | $256K | $668K | $144K | $178K | $208K |
| Gyre | — | — | $0 | $79K | — | — | $0 | $54K |
| All Other Segments | — | — | — | — | — | — | $0 | $0 |
| Total | — | — | — | — | — | — | — | — |